Bioprinting Markets Materials, Equipment and Applications Opportunity Analysis and Forecast to 2027

Analysis suggests that by 2027, bioprinting applications will generate over $1 billion in revenue, accompanied by a healthy market in specialist bioprinting hardware and materials.

Read Full Report at http://www.reportsnreports.com/reports/954218-bioprinting-markets-materials-equipment-and-applications-2017-to-2027-an-opportunity-analysis-and-ten-year-forecast.html

Potential for the bioprinting sector has increased considerably in the past couple of years. What we are seeing is that:

Bioprinters themselves have technologically matured and
They have also become more accessible in terms of cost to a wider target of users -- low-cost desktop bioprinters are available at below $20,000.
Meanwhile, bioprinting is experiencing a rapid transformation from basic research in academic laboratories to an emerging industry due to its near-term potential in areas such as drug discovery, personalized medicine, regenerative medicine, cosmetics testing, medical devices and food manufacturing. While printing complete organs still seems a long way off, revenues from bioprinting are already being generated from these more immediate applications.

Get Sample copy of this Report @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=954218 OR Check for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=954218

The report explores the commercial implications of bioprinting in depth and includes:

· Ten-year forecasts of bioprinting materials, hardware and applications markets. Materials are broken out by type and forecasted hardware is presented by both unit sales and in revenue terms, with breakouts by process technology and price point. Revenues for bioprinting applications are segmented by the type of application – specifically, drug discovery, cosmetics testing, medical devices and tissue regeneration.

· Highly granular information about current pricing of both bioprinters and printing materials for bioprinting applications. In addition, the report provides detailed information on which companies and institutions are using bioprinters today and which printers they are using.

· An assessment of the product/market strategies of emerging and established firms in the bioprinting space. While many of the firms pioneering this space are well-funded and innovative start-ups, bioprinting is also attracting the attention of some of the largest multinationals in big pharma and cosmetics, for example. Astellas Pharma, Bristol-Meyers Squibb, Merck, Novartis, Procter and Gamble, Roche and others all have bioprinting programs, as do some of the large research facilities in the world, such as the National Institutes of Health in the US. Meanwhile, bioprinting continues to be a favorite target of venture capital firms.

· A full discussion of the latest developments in droplet and extrusion bio printer and what they mean both technically and from a business perspective. Also included is an analysis of the very diverse market for bioprinted materials. Emerging bioinks, include combinations of polymers, ceramics, cells, cell aggregates, peptides, growth factors, hydrogels, scaffold components, and other materials.

Get a copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=954218

Table of Contents

Chapter One: The 3D Bioprinting Market in 2016
1.1 Key Trends in 3D Bioprinting Driving Hardware Demand
1.1.1 Analysis of Commercially Viable 3D Bioprinting Applications
1.1.2 The Promise of 3D-Printed Organs
1.1.3 How 3D Cell Culture is Affecting Medical Research
1.2 The 3D Bioprinting Industry
1.2.1 The Market for Bioprinting Materials
1.2.2 How Low Cost and Open Source Bioprinting is Affecting the Competitive Landscape
1.3 Objective of this Report
1.4 Methodology of this Report

Chapter Two: 3D Bioprinting Processes, Hardware and Materials
2.1 Origins of Bioprinting
2.2 Laser-Assisted Bioprinting (LaBP) Methods
2.3 Stereolithography
2.4 Laser Free Bioprinting Methods (LfBP)
2.5 Other Methods
2.5.1 Electrospinning
2.5.2 Magnetic Levitation (n3D)
2.5.3 The Kenzan Method
2.6 Post Processing: The Bioreactor
2.7 Materials for 3D Bioprinting

Chapter Three: The Present and Future of 3D Bioprinting Applications
3.1 Tissue Regeneration
3.1.1 Cartilage
3.1.2 Skin
3.1.3 Bones
3.1.4 Blood Vessels
3.2 Complex Organs: the Billion Cell Construct
3.2.1 Thyroid and Pancreas
3.2.2 Kidney
3.2.3 Liver
3.2.4 Heart and Valves
3.2.5 Brain
3.3 Research
3.3.1 Drug Toxicity Testing and Screening
3.3.2 In-Vitro Organ Models and the “Organ-on-a-Chip”
3.3.3 Cosmetics
3.4 Cellular Agriculture

Chapter Four: Analysis of the 3D Bioprinting Competitive Landscape
4.1 Leading Hardware Manufacturers
4.2 Low-Cost Hardware and Commercial Bioink Manufacturers
4.3 Major Universities and Associations in 3D Bioprinting Research
4.4 Commercial Bioprinting Research Firms

Chapter Five: Ten-Year 3D Bioprinting Market Forecasts – Hardware, Materials and Research
5.1 Limiting Factors
5.2 The 3D Bioprinting Market: Hardware, Materials and Applications: Ten-Year Forecast
5.2.1 Ten-Year Forecast of 3D Bioprinting Hardware Market
5.3 Ten-Year Bioink Forecast
5.3.1 Hydrogels and Scaffolding Materials Sales and Demand
5.3.2 Scaffolding Materials Sales and Demand
5.3.3 Matrix Materials Sales and Demand
5.4 Ten-Year Forecast for 3D Bioprinting Research and Tissue Regeneration Applications

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Ritesh Tiwari
Tel: +1-888-391-5441
sales@reportsandreports.com

This release was published on openPR.